These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4329953

  • 1. Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy.
    Stolfi RL, Martin DS, Fugmann RA.
    Cancer Chemother Rep; 1971 Jun; 55(3):239-51. PubMed ID: 4329953
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced cures of spontaneous murine mammary carcinomas with surgery and five-compound combination chemotherapy, and their immunotherapeutic interrelationship.
    Fugmann RA, Martin DS, Hayworth PE, Stolfi RL.
    Cancer Res; 1970 Jul; 30(7):1931-6. PubMed ID: 5456078
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
    Stolfi RL, Fugmann RA, Stolfi LM, Martin DS.
    Int J Cancer; 1974 Mar 15; 13(3):389-403. PubMed ID: 4822108
    [No Abstract] [Full Text] [Related]

  • 5. Use of first generation transplants of a slow growing solid tumor for the evaluation of new cancer chemotherapeutic agents.
    Sandberg J, Goldin A.
    Cancer Chemother Rep; 1971 Jun 15; 55(3):233-8. PubMed ID: 5115845
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced cures of spontaneous murine mammary tumors with surgery, combination chemotherapy, and immunotherapy.
    Martin DS, Hayworth PE, Fugmann RA.
    Cancer Res; 1970 Mar 15; 30(3):709-16. PubMed ID: 5425293
    [No Abstract] [Full Text] [Related]

  • 9. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
    Sacco MG, Benedetti S, Duflot-Dancer A, Mesnil M, Bagnasco L, Strina D, Fasolo V, Villa A, Macchi P, Faranda S, Vezzoni P, Finocchiaro G.
    Gene Ther; 1996 Dec 15; 3(12):1151-6. PubMed ID: 8986442
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL.
    J Natl Cancer Inst; 1969 Feb 15; 42(2):311-20. PubMed ID: 4303883
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL, Miller GF, Wood DA.
    J Natl Cancer Inst; 1969 Feb 15; 42(2):289-301. PubMed ID: 4303881
    [No Abstract] [Full Text] [Related]

  • 14. Characterization of a slow-growing, transplantable rat mammary tumor (MCR-83): a model for endocrine-related cell kinetic studies.
    van Dierendonck JH, Cornelisse CJ, van der Linden PW, van Putten LM, van de Velde CJ.
    Cancer Res; 1987 Aug 01; 47(15):4093-8. PubMed ID: 3607751
    [Abstract] [Full Text] [Related]

  • 15. Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.
    Bogden AE, Esber HJ, Taylor DJ, Gray JH.
    Cancer Res; 1974 Jul 01; 34(7):1627-31. PubMed ID: 4857731
    [No Abstract] [Full Text] [Related]

  • 16. The delayed and lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with use of killed Bordetella pertussis.
    Likhite VV.
    Cancer Res; 1974 May 01; 34(5):1027-30. PubMed ID: 4363061
    [No Abstract] [Full Text] [Related]

  • 17. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY, Ma KS, Guan JF.
    Zhonghua Zhong Liu Za Zhi; 1980 Sep 01; 2(3):168-73. PubMed ID: 7227180
    [No Abstract] [Full Text] [Related]

  • 18. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
    Griswold DP.
    Cancer Treat Rep; 1986 Jan 01; 70(1):81-6. PubMed ID: 3943116
    [No Abstract] [Full Text] [Related]

  • 19. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW, Benjamin SA.
    J Natl Cancer Inst; 1972 Nov 01; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract] [Full Text] [Related]

  • 20. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma.
    Cavallo F, Di Pierro F, Giovarelli M, Gulino A, Vacca A, Stoppacciaro A, Forni M, Modesti A, Forni G.
    Cancer Res; 1993 Nov 01; 53(21):5067-70. PubMed ID: 8221636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.